1056264-66-4 Usage
Uses
Used in Pharmaceutical Industry:
2-bromo-3-chloro-6-fluorobenzaldehyde is used as an intermediate in the synthesis of various pharmaceuticals. Its unique structure and functional groups allow for the development of new drugs with specific therapeutic properties. 2-bromo-3-chloro-6-fluorobenzaldehyde's reactivity and stability make it a preferred choice for the production of diverse medicinal agents.
Used in Agrochemical Industry:
In the agrochemical sector, 2-bromo-3-chloro-6-fluorobenzaldehyde serves as a key intermediate for the synthesis of various agrochemicals, including pesticides and herbicides. Its chemical properties enable the creation of effective and targeted agrochemicals that can protect crops and enhance agricultural productivity.
Used in Organic Synthesis:
2-bromo-3-chloro-6-fluorobenzaldehyde is utilized as a valuable building block in organic synthesis. Its presence of bromine, chlorine, and fluorine atoms allows for a wide range of chemical reactions, leading to the formation of diverse organic compounds with various applications in different industries.
Overall, 2-bromo-3-chloro-6-fluorobenzaldehyde plays a crucial role in the chemical industry, serving as a versatile and essential tool for the creation of numerous important products across various fields.
Check Digit Verification of cas no
The CAS Registry Mumber 1056264-66-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,5,6,2,6 and 4 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1056264-66:
(9*1)+(8*0)+(7*5)+(6*6)+(5*2)+(4*6)+(3*4)+(2*6)+(1*6)=144
144 % 10 = 4
So 1056264-66-4 is a valid CAS Registry Number.
1056264-66-4Relevant academic research and scientific papers
METHODS OF TREATING CREATINE TRANSPORTER DEFICIENCY
-
Paragraph 0537-0538, (2021/10/02)
Disclosed are methods of treating creatine transporter deficiency, comprising administering to a mammal in need thereof a therapeutically effective amount of a compound that increases transport of a substrate by a mutant or wild-type creatine transporter. Also disclosed are methods of increasing transport of guanidinoacetic acid or a salt thereof across the blood-brain barrier of a mammal, and methods of decreasing accumulation or the concentration of guanidinoacetic acid or a salt thereof in a mammalian cell.
SMALL MOLECULES TARGETING MUTANT MAMMALIAN PROTEINS
-
Paragraph 0676; 0677, (2021/12/03)
Disclosed are compounds, compositions, and methods useful for treating or preventing a disease or disorder associated with a mutation in a protein.
INDAZOLES USED TO TREAT ESTROGEN RECEPTOR BETA MEDIATED DISORDERS
-
Page/Page column 25-26, (2008/12/07)
The present invention relates to novel indazole derivatives (I) having pharmacological activity, processes for their preparation, compositions containing them and uses of these compounds in the treatment of estrogen receptor beta mediated diseases.
